Opinion: Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress

Proposed cuts will have “a catastrophic effect on the advancement of biomedical and biotechnology capabilities in the United States,” more than 100 leaders of biomedical/health sciences companies tell Congress.